Chapter 4 Catamenial Epilepsy

International Review of Neurobiology

Volumn 83, Issue , 2008, Pages 79-90

  Penovich, Patricia E ^a   Helmers, Sandra ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT;

EPILEPSY; FEMALE; HUMAN; MALE; MENSTRUAL CYCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; SEXUAL DEVELOPMENT;

ANTIEMETICS; EPILEPSY; FEMALE; HUMANS; MALE; MENSTRUAL CYCLE; SEX CHARACTERISTICS;

EID: 53049103578     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(08)00004-4     Document Type: Review

References (41)

1. Ansell B., and Clarke E. Epilepsy and menstruation: The role of water retention. Lancet 2 (1956) 1232-1235
2. Bixo M., Andersson A., Winblad B., Purdy R., and Backstrom T. Progesterone, 5α-pregnane-3, 2-dione and 3α-hydroxy-5α-pregnane-2-one in specific regions of the human female brain in different endocrine states. Brain Res. 764 (1997) 173-178
3. Edwards H.E., Burnham W.M., Ng M.M., Asa S., and MacLusky N.J. Limbic seizure alters reproduction function in the female rat. Epilepsia 40 (1999) 1370-1377
4. Edwards H.E., MacLusky N.J., and Burnham W.M. The effect of seizures and kindling on reproductive hormones in the rat. Neurosci. Biobehav. Rev. 24 7 (2000) 753-762
5. Feely M., and Gibson J. Intermittent clobazam for catamenial epilepsy: Tolerance avoided. J. Neurol. Neurosurg. Psychiatr. 47 (1984) 1279-1282
6. Feely M., Calvert R., and Gibson J. Clobazam in catamenial epilepsy: A model for evaluating anticonvulsants. Lancet 2 (1982) 71-73
7. Fredericksen M.C. Depo medroxyprogesterone acetate contraception in women with medical problems. J. Reprod. Med. 41 (1996) 414-418
8. Foldvary-Schaefer N., and Falcone T. Catamenial epilepsy: Pathophysiology, diagnosis, and management. Neurology 61 Suppl. 2 (2003) S2-S15
9. Gowers W.R. Epilepsy and Other Chronic Convulsive Diseases. Their Causes, Symptoms, and Treatment (1881), J & A, Churchill, London
10. Herzog A.G. Clomphene therapy in epileptic women with menstrual disorders. Neurology 38 (1988) 432-434
11. Herzog A.G. Progesterone therapy in women with complex partial and secondarily generalized seizures. Neurology 45 (1995) 1660-1662
12. Herzog A.G. Progesterone therapy in women with epilepsy: A 3-year follow-up. Neurology 52 (1999) 1917-1918
13. Herzog A.G. Psychoneuroendocrine aspects of temporolimbic epilepsy, Part I: Brain, reproductive steroids and emotions. Psychosomatics 40 (1999) 95-101
14. Herzog A.G. Psychoneuroendocrine aspects of temporolimbic epilepsy, Part II: Epilepsy and reproductive steroid. Psychosomatics 40 (1999) 102-108
15. Herzog A.G., and Frye C.A. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann. Neurol. 53 (2003) 390-391
16. Herzog A.G., Klein P., and Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia 38 (1997) 1082-1088
17. Herzog A.G., Harden C.L., Liporace J., Pennel P., et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol. 56 (2004) 431-434
18. Karkuzhali B., and Schomer D.L. Weekly fluctuation and adjustment of antiepileptic drugs to treat catamenial seizures. Epilepsia 39 (1998) 179
19. Krugers H.J., Knollema S., Kemper R.H., TerHorst G.J., and Kor F.J. Down regulation of the hypothalamic-pituitary-adrenal axis reduces brain damage and number of seizures following hypoxia/ischaemia in rats. Brain Res. 690 (1995) 41-47
20. Kumar N., Behari M., Ahuja G.K., and Jailkhani B.L. Phenytoin levels in catamenial epilepsy. Epilepsia 29 (1988) 155-158
21. Lim L.L., Foldvary N., Mascha E., and Lee J. Acetazolamide in women with catamenial epilepsy. Epilepsia 42 (2001) 746-749
22. Locock C. Analysis of fifty-two cases of epilepsy observed by the author. In Med. Times Gaz. 14 (1857) 524-526
23. Logothetis J., Harner R., Morrell F., and Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 9 (1959) 352-360
24. Lombroso C.T., and Forxythe I. A long-term follow-up of acetazolamide in the treatment of epilepsy. Epilepsia 1 (1960) 493-500
25. Loy R., Gerlach J.L., and McEwen B.S. Autoradiographic localization of estradiol-binding neurons in the rat hippocampal formation and entorhinal cortex. Brain Res. 46 (1988) 245-251
26. Maguire J.L., Stell B.M., Rafizadeh M., and Mody I. Ovarian cycle-linked changes in receptors mediating tonic inhibition after seizure susceptibility and anxiety. Nat. Neurosci. 8 (2005) 797-804
27. Majewska M.D., Harrison N.L., and Schwartz R.D. Steroid hormone metabolites are barbiturate-like modulators of the GABA-A receptor. Science 232 (1986) 1004-1007
28. Mattson R.H., Cramer J.A., Caldwell B.V., and Siconolfi B.C. Treatment of seizures with medroxyprogesterone acetate: Preliminary report. Neurology 34 (1984) 1255-1258
29. McAuley J.W., Moore J.L., Reeves A.L., et al. A pilot study of the neurosteriod ganaxolone in catamenial epilepsy: Clinical experience in two patients. Epilepsia 42 (2001) 85
30. McEwen B.S. Nongenomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12 (1991) 141-147
31. Morrell M.J., Hamdy S.F., Seale C.G., and Springer E.A. Self-reported reproductive history in women with epilepsy: Puberty onset and effects of menarche and menstrual cycle on seizures. Neurology 50 (1998) 448
32. Murialdo G., Galimberti C.A., Magri F., et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J. Endocrinol. Invest. 20 (1997) 519-526
33. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
34. Pfaff D., and Kerner M. Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J. Comp. Neurol. 151 (1973) 121-158
35. A receptor subunit mRNA expression in NT2-N neurons. Brain Res. Mol. Brain Res. 138 (2005) 105-115
36. Reddy D.S. Pharmacology of catamenial epilepsy. Exp. Clin. Pharmacol. 26 (2004) 547-561
37. Reddy D.S., Kim H., and Rogowski M.A. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 42 (2001) 328-336
38. Shavit G., Lerman P., Korczyn A., Kivity S., Bechar M., and Gitter S. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology 34 (1984) 959-961
39. Smith S.S. Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res. 503 (1989) 354-357
40. Temkin O. The Falling Sickness: A History of Epilepsy from the Greeks to the Beginnings of Modern Neurology. 2nd revised ed. (1971), Johns Hopkins Press, Baltimore
41. Woodbury D.M. Effect of adrenocortical steroids and adrenocorticotropic hormone on electroshock seizure threshold. J. Pharmacol. Exp. Ther. 105 (1952) 27-36